Accredo
Privacy |  HIPAA |  Terms of use |  Medco |  Contact us
   
Patients Healthcare professionals Health plans & payor clients Manufacturers Careers About Accredo
 
 
 

Patients

Getting started with Accredo
Our services
Search drug therapies
Therapy management
Revlimid® (lenalidomide) - overview

Revlimid® (lenalidomide)

Overview | Product information | Accredo services | Contact team


Myelodysplastic syndromes (MDS) are a rare group of blood disorders that occur as a result of improper development of blood cells within the bone marrow. The three main types of blood cells—red blood cells, white blood cells, and platelets—are affected. Red blood cells deliver oxygen to the body, white blood cells help fight infections, and platelets assist in clotting to stop blood loss. These improperly developed blood cells fail to develop normally and enter the bloodstream. As a result, individuals with MDS have abnormally low blood cell levels (low blood counts). General symptoms associated with MDS include fatigue, dizziness, weakness, bruising and bleeding, frequent infections, and headaches.

Multiple myeloma is a cancer of the plasma cells, a type of white blood cell present in your bone marrow. Plasma cells are a crucial part of the immune system responsible for the production of antibodies which fight infection.

Referral Form

Other Resources:

Aplastic Anemia & MDS International Foundation

NORD - National Organization for Rare Diseases

Revlimid.com


Revlimid is a registered trademark of Celgene Corporation

 
 
 

Quick links

Search Search drug therapies
Doctor Referral Doctor referral forms
Patient Authorization Patient authorization form
Contact Us Contact us